3/4/24 18:12 | 3/4/24 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Jacobs Bruce N. | MA | O | CFO | S.d | -165 | 41.86 | 0 | -4 | -3 | 142 | D | | | | | | | | | | | | | | |
6/2/23 14:17 | 6/2/23 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Jacobs Bruce N. | MA | O | CFO | M.d | 21 | 2.08 | 0 | 10 | 10 | 115 | D | | | | | | | | | | | | | | |
3/3/23 16:30 | 3/2/23 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Jacobs Bruce N. | MA | O | CFO | S.d | -42 | 31.00 | 0 | -1 | -1 | 105 | D | | | | | | | | | | | | | | |
10/24/22 08:00 | 10/21/22 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Jacobs Bruce N. | MA | O | CFO | M.d | 21 | 2.08 | 0 | 10 | 14 | 81 | D | | | | | | | | | | | | | | |
10/17/22 20:12 | 10/17/22 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Jacobs Bruce N. | MA | O | CFO | M.d | 21 | 2.08 | 0 | 10 | 16 | 71 | D | | | | | | | | | | | | | | |
5/3/22 19:26 | 5/3/22 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Jacobs Bruce N. | MA | O | CFO | M.d | 42 | 2.08 | 0 | 20 | 49 | 61 | D | | | | | | | | | | | | | | |
1/14/22 17:15 | 1/14/22 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Jacobs Bruce N. | MA | O | CFO | M.d | 21 | 2.08 | 0 | 10 | 57 | 28 | D | | | | | | | | | | | | | | |
1/14/22 17:01 | 1/12/22 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Jacobs Bruce N. | MA | O | CFO | M.d | 31 | 2.08 | 0 | 15 | 597 | 18 | D | | | | | | | | | | | | | | |
1/14/22 17:01 | 1/12/22 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Jacobs Bruce N. | MA | O | CFO | S.d | -778 | 51.85 | 0 | -15 | -46 | 18 | D | | | | | | | | | | | | | | |
12/3/21 18:43 | 12/3/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Jacobs Bruce N. | MA | O | CFO | M.d | 21 | 2.08 | 0 | 10 | 133 | 18 | D | | | | | | | | | | | | | | |
12/3/21 18:43 | 12/3/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Jacobs Bruce N. | MA | O | CFO | S.d | -536 | 53.56 | 0 | -10 | -36 | 18 | D | | | | | | | | | | | | | | |
11/23/21 16:59 | 11/23/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Jacobs Bruce N. | MA | O | CFO | M.d | 21 | 2.08 | 0 | 10 | 138 | 17 | D | | | | | | | | | | | | | | |